<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02781896</url>
  </required_header>
  <id_info>
    <org_study_id>EASY TAVI 2016</org_study_id>
    <nct_id>NCT02781896</nct_id>
  </id_info>
  <brief_title>Direct Left Ventricular Rapid Pacing Via the Valve Delivery Guide-wire in TAVI</brief_title>
  <acronym>EASY TAVI</acronym>
  <official_title>Direct Left Ventricular Rapid Pacing Via the Valve Delivery Guide-wire in TAVI: a Randomized Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Groupe Hospitalier Mutualiste de Grenoble</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Centre Recherche Cardio Vasculaire Alpes</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Groupe Hospitalier Mutualiste de Grenoble</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether a left ventricular rapid pacing using the
      valve delivery guide-wire in transcatheter aortic valve implantation (TAVI) reduces the
      overall procedure duration in comparison with the conventional method.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Use of temporary pacing via a right ventricular lead in TAVI is still mandatory to ensure
      transient cardiac standstill while predilatation is performed and the valve is being
      positioned and deployed. This requires an additional venous vascular access and a pacing
      catheter which are both likely to generate complications.

      This study compares the standard right ventricular rapid pacing to a new and simplified
      technique : a left ventricular rapid pacing is provided via the back-up 0.035 &quot; guidewire.
      The cathode of an external pacemaker is placed on the tip of the 0.035&quot; wire and the anode on
      a needle inserted into the groin. Insulation is ensured by the balloon or TAVI catheter.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 12, 2017</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total TAVI procedural duration</measure>
    <time_frame>1 month</time_frame>
    <description>Duration of TAVI procedure is calculated from the first puncture to the last sheath removal</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Efficacy of the experimental technique to create a blood pressure drop reaching at least 60 mmHg (Ventricular stimulation efficiency)</measure>
    <time_frame>1 month</time_frame>
    <description>Stimulation efficiency is defined as a drop in systolic blood pressure reaching at least 60 mmHg during the prolonged stimulation without loss of capture for more than 30s.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of the experimental technique on succes rate of the intervention, fluoroscopy time, radiation exposure, Major adverse cardiovascular event and tamponades (Safety)</measure>
    <time_frame>1 month</time_frame>
    <description>Safety includes success of the intervention, fluoroscopy time, radiation exposure, Major adverse cardiovascular event and tamponades</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of the experimental technique on direct and indirect costs (Cost-effectiveness)</measure>
    <time_frame>1 month</time_frame>
    <description>Study costs includes direct costs (material used for the rapid pacing) and indirect costs (medical complications)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Aortic Valve Stenosis</condition>
  <arm_group>
    <arm_group_label>Right ventricular pacing</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Rapid pacing during TAVI is provided by a temporary pacing catheter placed in the right ventricle. An additional venous vascular access is required.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Left ventricular pacing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Rapid pacing during TAVI is provided by the valve delivery guidewire inserted into the left ventricle using two alligator clamps. One clamp is attached directly to the skin at the femoral entry site, the other is attached to the body of the valve delivery guidewire. No additional venous vascular access is required.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>pacing catheter</intervention_name>
    <description>Rapid pacing during TAVI is required to ensure transient cardiac standstill while predilatation is performed and the valve is being positioned and deployed. In the right ventricular pacing arm, rapid pacing is provided by a standard right ventricular pacing catheter.</description>
    <arm_group_label>Right ventricular pacing</arm_group_label>
    <other_name>transvenous stimulation electrode</other_name>
    <other_name>pacing lead</other_name>
    <other_name>pacing wire</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>valve delivery guidewire</intervention_name>
    <description>Rapid pacing during TAVI is required to ensure transient cardiac standstill while predilatation is performed and the valve is being positioned and deployed. In the Left ventricular pacing arm, rapid pacing is provided via the valve-delivery guidewire inserted into the left ventricle. The cathode of an external pacemaker is placed on the external end of the guidewire using an alligator clamp. The TAVI catheter provides the necessary insulation. The anode is attached directly to the subcutaneous tissue at the femoral entry site (also using an alligator clamp).</description>
    <arm_group_label>Left ventricular pacing</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject is eligible for a TAVI

          -  Access considered for aortic valve bioprothesis delivery is transfemoral

          -  Aortic valve bioprothesis considered is Edwards Sapien 3® et/ou XT®

          -  Subject is ≥ 18 years of age

          -  Subject has signed informed consent form

        Exclusion Criteria:

          -  Pregnancy

          -  Subject already included in this study

          -  Subject included in another study and whose inclusion in EASY TAVI implies a deviation
             in either study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Benjamin Faurie</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Recherche Cardio Vasculaire Alpes</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Thierry Lefèvre</last_name>
    <role>Principal Investigator</role>
    <affiliation>Massy</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Angélique Grangier</last_name>
    <phone>+33476707440</phone>
    <email>agrangier.crca@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Valérie ARMAND</last_name>
    <phone>+33476285081</phone>
    <email>v.armand@ghm-grenoble.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU Clermont Ferrand</name>
      <address>
        <city>Clermont-Ferrand</city>
        <state>Auvergne-Rhône-Alpes</state>
        <zip>63000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Géraud Souteyrand</last_name>
      <phone>+334 73 75 14 10</phone>
      <email>gsouteyrand@chu-clermontferrand.fr</email>
    </contact>
    <investigator>
      <last_name>Géraud Souteyrand</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Annecy Genevois</name>
      <address>
        <city>Epagny</city>
        <state>Auvergne-Rhône-Alpes</state>
        <zip>74370</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angélique Grangier</last_name>
      <phone>+33476707440</phone>
      <email>agrangier.crca@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Lionel Mangin</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique du Tonkin</name>
      <address>
        <city>Villeurbanne</city>
        <state>Auvergne-Rhône-Alpes</state>
        <zip>69100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angélique Grangier</last_name>
      <phone>+33476707440</phone>
      <email>agrangier.crca@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Patrick Staat</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institut Mutualiste Montsouris</name>
      <address>
        <city>Paris</city>
        <state>Ile De France</state>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angélique Grangier</last_name>
      <phone>+33476707440</phone>
      <email>agrangier.crca@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Christophe Caussin</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Groupement Hospitalier Mutualiste de Grenoble</name>
      <address>
        <city>Grenoble</city>
        <state>Isère</state>
        <zip>38028</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angélique Grangier</last_name>
      <phone>+33476707440</phone>
      <email>agrangier.crca@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Benjamin Faurie</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital privé Jacques Cartier</name>
      <address>
        <city>Paris</city>
        <state>Massy</state>
        <zip>91300</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thierry Lefèvre, Dr</last_name>
      <phone>+331 60 13 46 02</phone>
      <email>t.lefevre@angio-icps.com</email>
    </contact>
    <investigator>
      <last_name>Thierry Lefèvre</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique Saint-Hilaire</name>
      <address>
        <city>Rouen</city>
        <state>Normandie</state>
        <zip>76000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mathieu Godin</last_name>
      <phone>+332 35 08 66 21</phone>
      <email>matthieugodin@yahoo.fr</email>
    </contact>
    <investigator>
      <last_name>Mathieu Godin</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique Pasteur</name>
      <address>
        <city>Toulouse</city>
        <state>Occitanie</state>
        <zip>31300</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angélique Grangier</last_name>
      <phone>+33476707440</phone>
      <email>agrangier.crca@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Nicolas Dumonteil</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institut Arnault Tzanck</name>
      <address>
        <city>Saint-Laurent-du-Var</city>
        <state>Provence-Alpes-Côte d'Azur</state>
        <zip>06721</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre Meyer</last_name>
      <phone>+334 92 27 38 67</phone>
      <email>pym.meyer@orange.fr</email>
    </contact>
    <investigator>
      <last_name>Pierre Meyer</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <link>
    <url>http://onlinelibrary.wiley.com/doi/10.1002/ccd.24474/full</url>
    <description>Guerios EE, W. P. (2013). Left ventricular guidewire pacing for transcatheter aortic valve implantation. CCI, E919-21.</description>
  </link>
  <link>
    <url>https://www.colorado.edu/economics/morey/7818/MoodGraybillBoesBook/MGB3rdSearchable.pdf</url>
    <description>Mood AM, G. F. (1974). Introduction to the heory of statistics. 3rd edition. New York: Mc Graw-Hill.</description>
  </link>
  <reference>
    <citation>Adams DH, Popma JJ, Reardon MJ, Yakubov SJ, Coselli JS, Deeb GM, Gleason TG, Buchbinder M, Hermiller J Jr, Kleiman NS, Chetcuti S, Heiser J, Merhi W, Zorn G, Tadros P, Robinson N, Petrossian G, Hughes GC, Harrison JK, Conte J, Maini B, Mumtaz M, Chenoweth S, Oh JK; U.S. CoreValve Clinical Investigators. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014 May 8;370(19):1790-8. doi: 10.1056/NEJMoa1400590. Epub 2014 Mar 29.</citation>
    <PMID>24678937</PMID>
  </reference>
  <reference>
    <citation>Arnold SV, Reynolds MR, Wang K, Magnuson EA, Baron SJ, Chinnakondepalli KM, Reardon MJ, Tadros PN, Zorn GL, Maini B, Mumtaz MA, Brown JM, Kipperman RM, Adams DH, Popma JJ, Cohen DJ; CoreValve US Pivotal Trial Investigators. Health Status After Transcatheter or Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Increased Surgical Risk: Results From the CoreValve US Pivotal Trial. JACC Cardiovasc Interv. 2015 Aug 17;8(9):1207-1217. doi: 10.1016/j.jcin.2015.04.018.</citation>
    <PMID>26292584</PMID>
  </reference>
  <reference>
    <citation>Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, Derumeaux G, Anselme F, Laborde F, Leon MB. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002 Dec 10;106(24):3006-8.</citation>
    <PMID>12473543</PMID>
  </reference>
  <reference>
    <citation>Cribier A, Eltchaninoff H, Tron C, Bauer F, Agatiello C, Sebagh L, Bash A, Nusimovici D, Litzler PY, Bessou JP, Leon MB. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol. 2004 Feb 18;43(4):698-703.</citation>
    <PMID>14975485</PMID>
  </reference>
  <reference>
    <citation>Eggebrecht H, Mehta RH, Kahlert P, Schymik G, Lefèvre T, Lange R, Macaya C, Mandinov L, Wendler O, Thomas M. Emergent cardiac surgery during transcatheter aortic valve implantation (TAVI): insights from the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry. EuroIntervention. 2014 Dec;10(8):975-81. doi: 10.4244/EIJV10I8A165.</citation>
    <PMID>24235321</PMID>
  </reference>
  <reference>
    <citation>Faurie B, Abdellaoui M, Wautot F, Staat P, Champagnac D, Wintzer-Wehekind J, Vanzetto G, Bertrand B, Monségu J. Rapid pacing using the left ventricular guidewire: Reviving an old technique to simplify BAV and TAVI procedures. Catheter Cardiovasc Interv. 2016 Nov 15;88(6):988-993. doi: 10.1002/ccd.26666. Epub 2016 Aug 11.</citation>
    <PMID>27510946</PMID>
  </reference>
  <reference>
    <citation>Gilard M, Eltchaninoff H, Iung B, Donzeau-Gouge P, Chevreul K, Fajadet J, Leprince P, Leguerrier A, Lievre M, Prat A, Teiger E, Lefevre T, Himbert D, Tchetche D, Carrié D, Albat B, Cribier A, Rioufol G, Sudre A, Blanchard D, Collet F, Dos Santos P, Meneveau N, Tirouvanziam A, Caussin C, Guyon P, Boschat J, Le Breton H, Collart F, Houel R, Delpine S, Souteyrand G, Favereau X, Ohlmann P, Doisy V, Grollier G, Gommeaux A, Claudel JP, Bourlon F, Bertrand B, Van Belle E, Laskar M; FRANCE 2 Investigators. Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med. 2012 May 3;366(18):1705-15. doi: 10.1056/NEJMoa1114705.</citation>
    <PMID>22551129</PMID>
  </reference>
  <reference>
    <citation>Karagöz T, Aypar E, Erdoğan I, Sahin M, Ozer S, Celiker A. Congenital aortic stenosis: a novel technique for ventricular pacing during valvuloplasty. Catheter Cardiovasc Interv. 2008 Oct 1;72(4):527-30. doi: 10.1002/ccd.21695.</citation>
    <PMID>18814234</PMID>
  </reference>
  <reference>
    <citation>Lefèvre T, Kappetein AP, Wolner E, Nataf P, Thomas M, Schächinger V, De Bruyne B, Eltchaninoff H, Thielmann M, Himbert D, Romano M, Serruys P, Wimmer-Greinecker G; PARTNER EU Investigator Group. One year follow-up of the multi-centre European PARTNER transcatheter heart valve study. Eur Heart J. 2011 Jan;32(2):148-57. doi: 10.1093/eurheartj/ehq427. Epub 2010 Nov 12.</citation>
    <PMID>21075775</PMID>
  </reference>
  <reference>
    <citation>Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S; PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010 Oct 21;363(17):1597-607. doi: 10.1056/NEJMoa1008232. Epub 2010 Sep 22.</citation>
    <PMID>20961243</PMID>
  </reference>
  <reference>
    <citation>Navarini S, Pfammatter JP, Meier B. Left ventricular guidewire pacing to simplify aortic balloon valvuloplasty. Catheter Cardiovasc Interv. 2009 Feb 15;73(3):426-7. doi: 10.1002/ccd.21810.</citation>
    <PMID>19213097</PMID>
  </reference>
  <reference>
    <citation>Popma JJ, Adams DH, Reardon MJ, Yakubov SJ, Kleiman NS, Heimansohn D, Hermiller J Jr, Hughes GC, Harrison JK, Coselli J, Diez J, Kafi A, Schreiber T, Gleason TG, Conte J, Buchbinder M, Deeb GM, Carabello B, Serruys PW, Chenoweth S, Oh JK; CoreValve United States Clinical Investigators. Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. J Am Coll Cardiol. 2014 May 20;63(19):1972-81. doi: 10.1016/j.jacc.2014.02.556. Epub 2014 Mar 19.</citation>
    <PMID>24657695</PMID>
  </reference>
  <reference>
    <citation>Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ, Anderson WN, Wang D, Pocock SJ; PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011 Jun 9;364(23):2187-98. doi: 10.1056/NEJMoa1103510. Epub 2011 Jun 5.</citation>
    <PMID>21639811</PMID>
  </reference>
  <reference>
    <citation>Thomas M, Schymik G, Walther T, Himbert D, Lefèvre T, Treede H, Eggebrecht H, Rubino P, Colombo A, Lange R, Schwarz RR, Wendler O. One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation. 2011 Jul 26;124(4):425-33. doi: 10.1161/CIRCULATIONAHA.110.001545. Epub 2011 Jul 11.</citation>
    <PMID>21747054</PMID>
  </reference>
  <reference>
    <citation>Walther T, Hamm CW, Schuler G, Berkowitsch A, Kötting J, Mangner N, Mudra H, Beckmann A, Cremer J, Welz A, Lange R, Kuck KH, Mohr FW, Möllmann H; GARY Executive Board. Perioperative Results and Complications in 15,964 Transcatheter Aortic Valve Replacements: Prospective Data From the GARY Registry. J Am Coll Cardiol. 2015 May 26;65(20):2173-80. doi: 10.1016/j.jacc.2015.03.034. Epub 2015 Mar 15.</citation>
    <PMID>25787198</PMID>
  </reference>
  <reference>
    <citation>Wenaweser P, Pilgrim T, Roth N, Kadner A, Stortecky S, Kalesan B, Meuli F, Büllesfeld L, Khattab AA, Huber C, Eberle B, Erdös G, Meier B, Jüni P, Carrel T, Windecker S. Clinical outcome and predictors for adverse events after transcatheter aortic valve implantation with the use of different devices and access routes. Am Heart J. 2011 Jun;161(6):1114-24. doi: 10.1016/j.ahj.2011.01.025. Epub 2011 May 11.</citation>
    <PMID>21641358</PMID>
  </reference>
  <reference>
    <citation>Vogel R, Meier B. Emergent mechanical and electrical guidewire pacing of the right ventricle for aystole in the cardiac catheterization laboratory. J Invasive Cardiol. 2005 Sep;17(9):490.</citation>
    <PMID>16145240</PMID>
  </reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 18, 2016</study_first_submitted>
  <study_first_submitted_qc>May 20, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 25, 2016</study_first_posted>
  <last_update_submitted>March 28, 2018</last_update_submitted>
  <last_update_submitted_qc>March 28, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 29, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>TAVI</keyword>
  <keyword>aortic valve bioprothesis</keyword>
  <keyword>TAVI simplification</keyword>
  <keyword>aortic stenosis</keyword>
  <keyword>rapid left ventricular pacing</keyword>
  <keyword>TAVR</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aortic Valve Stenosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

